MEDIX Cold & Flu Day & Night & COLES Cold & Flu Day & Night — recall
Health products · Australia · 2026-10-14
MEDIX and COLES Cold & Flu Day & Night, allergic reaction risk
→ See all Nova Pharmaceuticals Australasia recalls
| Country | Australia |
|---|---|
| Category | Health products |
| Published | 2026-10-14 |
| Company | Nova Pharmaceuticals Australasia Pty Ltd |
| Batch / expiry | All Batches within Expiry |
| Product type | Medicine |
| Registration no. (ARTG) | 353367, 353545 |
| Recall level | Consumer |
| Hazard class | Class I |
| Reason | Since 2019, listed medicines containing Andrographis paniculata (Andrographis) for supply in Australia have been required to carry a label warning about the risk of allergic reactions including severe reactions such as anaphylaxis. However, despite these warnings, the TGA has continued to receive a sustained high number of reports of anaphylaxis associated with Andrographis-containing listed medicines, which are considered low-risk medicines. Andrographis has now been removed from the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. This means the ingredient is no lon… |
| Recall type | Recall |
| Remedy | Distributors/Wholesalers • Inspect stock immediately and quarantine all stock of product on hand to prevent further use or distribution. • Return all affected stock on hand with the completed response form to Nova Pharmaceuticals. • Following receipt of returned stock and a completed response form, Nova Pharmaceuticals will contact customers to arrange refund or credit. Consumers • Consumers are advised that if they have the above product, to not use it. • Consumers can return the product to the place of purchase. • If someone is suspected of having anaphylaxis, call for emergency medical he… |
| Affected area | Australia |
| Recall number | RC-2026-RN-00809-1 |
| Official notice | View source ↗ |
Get alerted when Nova Pharmaceuticals Australasia has another recall
Free: we'll email you when Nova Pharmaceuticals Australasia appears in a new official recall across 11 markets, including the US, EU and Japan.
Watch Nova Pharmaceuticals Australasia recalls — free →What this means for sellers
| Likely platform / channel actions | Retailers/importers typically pull and return stock; similar products may face tighter border checks. |
|---|---|
| Self-check for comparable products | Check your comparable products' design, materials and QC records against the defect described here. |
| Rules & standards likely involved | the destination market's product-safety rules and mandatory standards |
🚨 Delisted or named by a regulator? Leave your details and situation — we'll assess and get back to you. Contact us →
General guidance only — not compliance or legal advice; the official notice and applicable law prevail.
Stay ahead of recalls like this
Get overseas recalls that matter to you (China-origin highlighted) + top hazards — one email a week. Free, unsubscribe anytime.
By subscribing you agree to our Privacy Policy & Terms (incl. cross-border data processing).
Related health products recalls
- Immunity Boost Forte (30s & 60s)Australia · 2026-10-14
- Fusion Health VIRAFORCE 30 and 60 CapsulesAustralia · 2026-10-14
- Chuan Xin Lian Antiphlogistic TabletAustralia · 2026-10-13
- Immunitone PlusAustralia · 2026-10-12
- My Immune Cold + FluAustralia · 2026-11-18
- Xiao Yan Li Dan Tablet, High Strength Chuan Xin Lian Antiphlogistic Tablet and Lian Zhi X…Australia · 2026-11-18
- Caruso’s Immune Aid 60 film coated tabletsAustralia · 2026-11-16